Larimar Therapeutics announced the appointment of Russell Clayton as chief medical officer, or CMO, effective immediately. Clayton succeeds former CMO Nancy Ruiz, who is retiring and will provide consulting support to the company as needed.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on LRMR: